NextBio Announces License Agreement with Genzyme Corporation

CUPERTINO, Calif.--(BUSINESS WIRE)--NextBio (www.nextbio.com) today announced that it has entered into a licensing agreement with Genzyme for use of its innovative life sciences data search engine and collaboration platform. “We were very impressed with NextBio's powerful search and data correlation features, quality and breadth of content and attention to detail in critical areas such as usability, security and scalability,” said Dr. Steve Madden, Director of Functional Genomics at Genzyme. “We believe that NextBio is a valuable resource that empowers our researchers to do better science and generate more focused hypotheses.”
MORE ON THIS TOPIC